The Current Ratio as of December 2024 (TTM) for Tryp Therapeutics Inc. (TRYPF) is 0.08

According to Tryp Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.08. This represents a change of -76.60% compared to the average of 0.36 of the last 4 quarters.

Tryp Therapeutics Inc. (TRYPF) Historical Current Ratio (quarterly & annually)

How has TRYPF Current Ratio performed in the past?

The mean historical Current Ratio of Tryp Therapeutics Inc. over the last ten years is 7.38. The current 0.08 Current Ratio has changed 13.39% with respect to the historical average. Over the past ten years (40 quarters), TRYPF's Current Ratio was at its highest in in the February 2021 quarter at 71.14. The Current Ratio was at its lowest in in the May 2021 quarter at 0.

Tryp Therapeutics Inc. (TRYPF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Tryp Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tryp Therapeutics Inc. (TRYPF) Average Current Ratio

How has TRYPF Current Ratio performed in the past?

The current Current Ratio of Tryp Therapeutics Inc. (TRYPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Tryp Therapeutics Inc. (TRYPF) Current Ratio vs. Peers

How is TRYPF’s Current Ratio compared to its peers?

Tryp Therapeutics Inc.’s Current Ratio is less than PsyBio Therapeutics Corp. (0), less than PharmaTher Holdings Ltd. (0.13), less than Awakn Life Sciences Corp. (7.98), less than SanBio Company Limited (0.51), less than Alterity Therapeutics Limited (5.30), less than Amplia Therapeutics Limited (3.54), less than Adynxx, Inc. (1.98), greater than Nxera Pharma Co., Ltd. (0), less than Biostage, Inc. (4.01), less than Antibe Therapeutics Inc. (1.79), less than America Great Health (10.06), greater than Cellectis S.A. (0.08), less than Biotron Limited (1.78), less than Regenicin, Inc. (0.58), greater than AXIM Biotechnologies, Inc. (0), greater than Bioasis Technologies Inc. (0.00), greater than Nova Mentis Life Science Corp. (0), greater than HAVN Life Sciences Inc. (0.02), greater than null (0),

Build a custom stock screener for Tryp Therapeutics Inc. (TRYPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tryp Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tryp Therapeutics Inc. (TRYPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tryp Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.